FindTrial
Sign In

Efficacy and Safety of YAG Laser Vitreolysis for the Treatment of Symptomatic Vitreous Floaters

Efficacy and Safety of YAG Laser Vitreolysis for the Treatment of Symptomatic Vitreous Floaters

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060001
Enrollment
Unknown
Registered
2022-05-14
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitreous Floaters

Interventions

Experimental group:YAG Laser Vitreolysis

Sponsors

Qingdao Eye Hospital of Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. After B-ultrasound, mydriasis fundus examination and infrared fundus photography, obvious turbidity focus could be seen, which corresponded to the patient's self-reported symptoms; 2. The distance between the opacity and the retina and lens is >3 mm; 3. The patient has a clear treatment intention.

Exclusion criteria

Exclusion criteria: 1. Complicated with obvious cataract, vitreous hemorrhage and other pathologic vitreous opacity; 2. Combined with vitreous proliferation, uveitis, fundus diseases and other serious eye diseases.

Design outcomes

Primary

MeasureTime frame
best-corrected visual acuity (BCVA);B-scan ultrasound;objective visual quality measures;contrast sensitivity function (CSF);National Eye Institute Visual Functioning Questionnaire-39 (NEI VFQ-39);infrared fundus photography;color fundus photograph;—

Countries

China

Contacts

Public ContactGao Yan
gao_yan912@163.com+86 18661778079

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026